Citations

Clear

13580 citation(s) found for "_, _".

Clinical, Endoscopic and Pathologic Findings of Submucosal Lesion of the Esophagus and Stomach: An Overview of the Common Submucosal Lesions of the Esophagus and Stomach With a Focus on the Clinical Presentation, Endoscopic and Radiologic Findings and Path
Macmillan, Katherine , Patil, Ameya, Yancey, Kristina , Fukami, Norio , Fukami, Norio , Patil, Ameya

Mayo Clinic

Foregut: The Journal of the American Foregut Society | April 21, 2026 | Volume: 6 | Issue: 2 | Pages: 196-206

10.1177/26345161261437707 Get It

Submucosal lesions of the esophagus and stomach are commonly discovered as incidental findings during routine endoscopy. These lesions arise from varying layers of the gastrointestinal wall, primarily from the submucosa or the muscularis propria, and can range from benign to malignant. This review provides an overview of common submucosal lesions including gastrointestinal stromal tumors (GIST), leiomyomas, duplication cysts, varices, glomus tumors, lipomas, granular cell tumors, neuroendocrine tumors, pancreatic rest, and schwannomas. We focus on their clinical presentation, endoscopic characteristics, radiologic features, and histopathologic findings to aid in diagnosis.
Addressing Depression From the Perspective of Cisgender Males: Mixed-Methods Insights on PHQ-9 Comfort Through the Health Belief Model and Gender Role Theory
Baulckim, La’ Tia

Mayo Clinic

INQUIRY: The Journal of Health Care Organization, Provision, and Financing | April 21, 2026 | Volume: 63 | Issue: No issue available | Pages: No page available

10.1177/00469580261441133 | PMID 42011043 Get It

Cisgender males remain less likely to report depressive symptoms or initiate mental health conversations with primary care providers. Guided by the Health Belief Model and Gender Role Theory, this study examined how cisgender males perceive and address depression, with a focus on their comfort with the Patient Health Questionnaire-9 and factors influencing their willingness to discuss mental health concerns. An anonymous mixed-methods survey link was disseminated to 62 cisgender males between November 2024 and January 2025. Quantitative items assessed preferences for mental health discussions, willingness to initiate conversations, and experiences with the PHQ-9. Qualitative responses were analyzed to identify perceived barriers, attitudes toward screening, and beliefs shaped by masculine role norms and health-belief constructs. Most participants (n = 48, 77.42%) preferred in-person mental health discussions with primary care providers. Half (n = 31, 50%) had previously received a mental health screener. Despite this, a large majority (n = 54, 87.10%) reported comfort completing screeners such as the PHQ-9 independently. However, n = 14 (22.58%) were unlikely to initiate mental health conversations. Qualitative findings revealed 3 dominant themes stigma, fear, and trust, that shaped comfort with screening and willingness to disclose symptoms. The HBM highlighted perceived barriers and low perceived susceptibility, while GRT contextualized how masculine norms discouraged disclosure. Cisgender males show readiness to engage with depression screeners when tools are accessible, yet stigma, fear, and trust remain central influences on disclosure. Integrating the PHQ-9 into routine primary care with deliberate conversations and strengthening patient-provider trust may enhance early identification of depression.
Genomic Confirmation of HLA‐DQB1*03:506:01:01 , by Next Generation Sequencing
Merschman, Jarret , Benidt, Derek, Kreuter, Justin D. , Barnes, Rachel, Gandhi, Manish J. , Kreuter, Justin, Gandhi, Manish

Mayo Clinic

HLA | April 21, 2026 | Volume: 107 | Issue: 4 | Pages: No page available

10.1111/tan.70726 | PMID 42059316 Get It

ABSTRACT The HLA‐DQB1*03:506:01:01 allele is characterised by a single nucleotide substitution in codon 130 in exon 3.
Genomic Confirmation of HLA‐C*14:84 , by Next Generation Sequencing
Merschman, Jarret , Benidt, Derek, Kreuter, Justin D. , Barnes, Rachel, Gandhi, Manish J. , Kreuter, Justin, Gandhi, Manish

Mayo Clinic

HLA | April 20, 2026 | Volume: 107 | Issue: 4 | Pages: No page available

10.1111/tan.70733 | PMID 42007826 Get It

ABSTRACT The HLA‐C*14:84 allele is characterised by a single nucleotide substitution in codon 181 in exon 3.
Minimally Invasive Arthroscopic Fixation of Scaphoid Nonunion in Adolescents Shows High Union Rates, Improved Function, and Low Morbidity
Kaempf, Ricardo, Fischer, Paula , Souza, William Brasil, Trivino, V Valenzuela, Trivino, Victor , Oliveira, Ricardo Kaempf de , Delgado, Pedro J. , Kakar, Sanjeev

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | April 20, 2026 | Volume: 8 | Issue: 1 | Pages: No page available

10.1002/ars2.70008 | PMID 42383105 Get It

Purpose To evaluate the clinical, radiographic, and functional outcomes of arthroscopic treatment of scaphoid nonunion in adolescents, using cancellous bone grafting combined with headless compression screw fixation. Methods This retrospective study included adolescent patients treated between 2015 and 2022 with arthroscopically assisted bone grafting and headless compression screw fixation for scaphoid nonunion. Inclusion criteria were nonunion ≥6 months after injury and minimum 12‐month follow‐up; exclusion criteria included degenerative wrist changes. Collected variables included demographic data, injury‐to‐surgery interval, radiographic parameters (including scapholunate angle), time to union, pain scores (visual analog scale), functional outcomes (QuickDASH), and range of motion. Statistical analysis showed significant improvements in visual analog scale and QuickDASH scores ( P < .05). Results Fifteen patients (14 males; mean age 16 years, range 13‐19) met inclusion criteria. The mean follow‐up was 29.2 months. All patients achieved bone union, with an average healing time of 5.7 weeks. Pain (visual analog scale) improved from 2.6 to 0.8, and QuickDASH scores improved from 26.5 to 7.9. The scapholunate angle improved from 60.6° to 46.6°, with stable range of motion postoperatively. No major complications or reoperations occurred. Minimal clinically important difference analysis confirmed meaningful clinical improvement in 93% of patients for pain and 87% for QuickDASH. Conclusions Arthroscopic treatment of scaphoid nonunion in adolescents shows high union rates, improved function, and low morbidity. Level of Evidence Level IV, therapeutic retrospective case series.
Return to sport after meniscectomy, meniscal repair, and meniscal allograft transplantation for meniscal lesions in athletes: A systematic review and meta‐analysis
Bensa, Alessandro , Piano, Andrea , Fumagalli, Giacomo Arthur, Krych, Aaron John, Verdonk, Peter, Krych, Aaron J. , Verdonk, Peter , Filardo, Giuseppe

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | April 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ksa.70404 | PMID 42003662 Get It

Abstract Purpose The aim of this systematic review and meta‐analysis was to quantify and compare the evidence on the results obtained with the surgical treatments for meniscal lesions in athletes. Methods A literature search was conducted on PubMed, Cochrane and Web of Science in August 2025 according to the PRISMA guidelines. Inclusion criteria were clinical studies (randomised controlled trials [RCTs], non‐randomised comparative studies and case series), ≥6 patients, in the English language, on the surgical treatment of meniscal lesions in athletes. A meta‐analysis was conducted on the rate of patients returning to sport, the time to return to sport, and the rate of patients returning to the pre‐injury level of sport. Patient‐reported outcome measures, adverse events, failures and reoperation rates, as well as risk of bias and quality of evidence, were also documented. The risk of bias was assessed using the Cochrane RoB 2.0 tool, the Cochrane ROBINS‐I tool, and the JBI Critical appraisal checklist. The quality of evidence was assessed using a modified Coleman score and the GRADE tool. Result The mean time to return to sport was 2.1 months for meniscectomy, 5.8 months for meniscal repair, and 8.9 months for meniscal allograft transplantation (MAT). Statistically significant differences were observed between meniscectomy and repair and between meniscectomy and MAT (both p < 0.001). Meniscectomy showed a return to sport rate of 98.2%, meniscal repair of 96.9%, and MAT of 94.2%, while return to the same pre‐injury level of sport was reported as 84.4% for meniscectomy, 81.3% for meniscal repair, and 77.4% for MAT, with no statistically significant differences between groups. The mean modified Coleman Methodology Score for the included studies was 66.6 ± 7.0. Conclusion Meniscectomy, meniscal repair, and MAT are all able to provide high rates of return to sport in athletes. In the investigated treatment cohorts, meniscectomy presented the shortest pooled time to return to sport, followed by meniscal repair and MAT. Importantly, all treatments offered good rates of return to the same level of athletic performance. The treatment choice should be guided by an individualised, multidisciplinary approach aimed at providing a patient‐tailored treatment strategy to optimise both athletic recovery and joint preservation. Level of Evidence Level I.
Femoral component collar and calcar contact during total hip arthroplasty: gap incidence, subsidence, and biomechanical testing - a scoping review
Yanamala, Sandeep , Alshaibi, Rakan , Nagelli, Christopher V. , Taunton, Michael, Hevesi, Mario, Kelly, John, Nagelli, Christopher, Kelly, John P. , Taunton, Michael J. , Hevesi, Mario , Yanamala, Sandeep R

Mayo Clinic

Orthopedic Reviews | April 20, 2026 | Volume: 18 | Issue: No issue available | Pages: No page available

10.52965/001c.160596 | PMID 42022231 Get It

Introduction In recent years collared femoral stems have been increasingly utilized in total hip arthroplasty (THA) for their ability to improve rotational stability, metaphyseal load transfer, and prevent periprosthetic femoral fracture (PFF). While literature has demonstrated their benefit over collarless stems, the clinical and biomechanical implications of a postoperative collar–calcar gap (CCG) after implantation remain incompletely understood. Objective The purpose of this scoping review was to evaluate existing literature around CCG in primary THA. Methods A PRISMA Scoping Review literature search was conducted across Ovid MEDLINE, Embase, Cochrane CENTRAL, and Scopus databases. Studies were included if they reported CCG incidence, subsidence, remodeling, or biomechanical performance in primary THA. Two independent reviewers screened studies and extracted data, and clinical study quality was assessed using the Newcastle–Ottawa Scale. Results A total of 408 studies were identified and 11 met inclusion criteria. The incidence of postoperative CCG varied from 18.7% to 53.9%. Most gaps demonstrated closure over time (66–76%). Biomechanical and finite element studies showed improved stability, reduced micromotion, and decreased periprosthetic fracture risk when direct collar–calcar contact was achieved. In contrast, stems with persistent gaps demonstrated increased subsidence (up to 19% vs 1.3%) and biomechanical behavior comparable to collarless designs. Conclusion CCG is common following THA. The majority of gaps resolve, however biomechanical evidence demonstrates that the advantages of collared stems depend on calcar contact. Preventing CCG may optimize early implant stability, though surgical technique must balance mechanical engagement with preservation of proximal femoral bone stock.
Abstract LB196: Fluorinated cuban-1-yl biguanides overcome hormone therapy resistance to standard of care fulvestrant, and palbociclib
Guo, Zhijun , Lei, Jianxun, Wells, Christian T., Makovec, Allison M., Yates, Andrew C., Hawse, John R. , McCarra, Joshua, Cao, Qing, Pryzbilla, Michael J., Koniar, Brenda, Norris, Beverly, Florey, Craig M., Schumacher, Robert J., Schwertfeger, Kaylee L., Ambrose, Elizabeth A., Wong, Henry, D'Assoro, Antonino, Goetz, Matthew P., Makovec, Allison , Jayaraman, Swaathi , Cao, Qing , Farrar, Michael A. , Schwertfeger, Kaylee, Ambrose, Elizabeth A. , Georg, Gunda I. , D’Assoro, Antonino B. , Goetz, Matthew P. , Potter, David A.

Mayo Clinic

Cancer Research | April 17, 2026 | Volume: 86 | Issue: 8_Supplement | Pages: LB196-LB196

10.1158/1538-7445.am2026-lb196 Get It

Abstract Introduction: Epoxy fatty acid (EpFA) mechanisms of hormone therapy resistance (HTR) in ER+HER2- breast cancer (BC) are poorly understood. EETs are EpFAs that contribute to BC progression and HTR by promoting oxidative phosphorylation (OXPHOS). However, it remains unclear how EETs contribute to HTR. In this study, two fulvestrant resistant (FR) subclones of the letrozole resistant (LR) MCF-7AC1 line were isolated (termed LR/FR) and were incidentally resistant to the CDKi palbociclib (PR) (termed MCF-7AC1 LR/FR/PR or multiply resistant - MCF-7AC1 MR). These HTR cell lines exhibited CYP3A4 upregulation (2.3- to 4.3-fold) and increased cellular (±)14,15-EET levels, which were suppressed by biguanide treatment (P&lt;0.05). Structure activity studies led to the design of hexyl cuban-1-yl biguanide (HCB) and fluorinated HCB derivatives C5F2-HCB and C6F3-HCB, which inhibited CYP3A4-mediated EET biosynthesis and growth of the HTR lines. HCB fluorination improved pharmacokinetics (PK) and toxicity. Methods: HCB and fluorinated HCBs were tested for impact on EET biosynthesis, OXPHOS, PK, and growth inhibition and reversal of hypoxia in the MCF-7AC1 MR tumor model. Results: Fulvestrant selection for MCF-7AC1 MR cell lines resulted in undetectable cyclin D1 and estrogen receptor (ERα) expression, while cyclin E1, CDK4, CDK6, CYP3A4, and c-MYC were upregulated (P&lt;0.001). MCF-7 MR cells demonstrated 1.8, 1.4, and 1.2- fold higher levels of (±)8,9, (±)11,12, and (±)14,15-EET compared to parental MCF-7 cells (P&lt;0.05). The most potent fluorinated HCB, C6F3-HCB, suppressed cellular levels of (±)8,9-EET, (±)11,12-EET, and (±)14,15-EET by 53-60% (P&lt;0.029). The MCF-7AC1 MR cells were more potently inhibited by HCBs and fluorinated derivatives compared to the MCF-7 cell line. Comparing an MCF-7 MR line vs. MCF-7, HCB exhibited IC50 values of 4.1 vs. 7.0 uM, C5F2-HCB 10 vs. 25 uM, and C6F3-HCB 5.4 vs. 12 uM (P values all &lt;0.05). C5F2-HCB exhibited the best PK and treatment of the MCF-7AC1 MR xenograft model showed reversal of hypoxia (P&lt;0.05) and transient inhibition by C5F2-HCB (P=0.025 at 20 days). P/F also transiently inhibited this model (P=0.006 at 20 days). C5F2-HCB and P/F showed synergy in vitro (CI=0.46) leading to testing of C5F2-HCB/P/F in vivo enabled by acceptable toxicity of the triplet in mice. This combination showed synergy in vivo vs. standard of care palbociclib/fulvestrant by nonparametric statistical tests (Mann Whitney; P=0.0389; Kolmogorov-Smirnov; P=0.0473), providing a pathway for possible clinical development of the combination. Conclusions: MR BC cell lines exhibit upregulation of CYP3A4 and biosynthesis of EETs, indicating a role for EETs in HTR. The C5F2-HCB/P/F exhibits activity against the highly resistant MCF-7 MR xenograft with acceptable toxicity indicating an avenue for clinical development. Citation Format: Zhijun Guo, Jianxun Lei, Christian T. Wells, Allison M. Makovec, Andrew C. Yates, Swaathi Jayaraman, John R. Hawse, Joshua A. McCarra, Qing Cao, Michael J. Pryzbilla, Brenda L. Koniar, Beverly J. Norris, Craig M. Florey, Robert J. Schumacher, Michael A. Farrar, Kaylee L. Schwertfeger, Elizabeth A. Ambrose, Henry Wong, Gunda I. Georg, Antonino D'Assoro, Matthew P. Goetz, David A. Potter. Fluorinated cuban-1-yl biguanides overcome hormone therapy resistance to standard of care fulvestrant, and palbociclib [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(8_Suppl):Abstract nr LB196.
Abstract LB324: The impact of the Community Living Lab learning health system on the prostate cancer knowledge, attitudes, beliefs, and cues to action of Black men
Odedina, Folakemi T., Bolajoko, Opeyemi , Wimberly, Quincy A., Lee, Daniel W. , Willis, Floyd B. , Moultrie, Toshiko, Ford, Wayne , Green, Derry , Merriweather, Arnold, Fudge, Michelle, Wimberly, Quincy , Fudge, Michelle

Mayo Clinic

Cancer Research | April 17, 2026 | Volume: 86 | Issue: 8_Supplement | Pages: LB324-LB324

10.1158/1538-7445.am2026-lb324 Get It

Abstract Background: Black men experience the highest burden of prostate cancer (CaP) incidence and mortality in the United States. The reasons documented for the significant burden of CaP in Black communities include health systems, care process, and individual/personal level factors, such as cultural factors, psychosocial factors, decision making/preferences, comprehension, past experience, and perceived behavioral control. The Community Living Lab (CoLLab) Learning Health System (LHS) was established within three American Legion Posts (ALP) in Northeast Florida to address these factors. Study Objective: This clinical trial study evaluated the impact of the CoLLab LHS on the knowledge, attitudes, beliefs, and cues to action of Black men who received Resources, Education, Amenities, and Community Health (REACH) services at the ALPs. Methods: The design was guided by the Intervention Mapping Framework and the Social Ecological Model. CoLLab REACH services were made available to participants through trusted community infrastructures. Services integrated include CaP resources and materials, social determinant of health navigation, healthy grocery distribution, cancer advocacy programs, and research participation. Participants were recruited at three ALPs and were asked to visit their respective CoLLab LHS site at least twice a month and up to 24 times over one year to use any of the services. The impact was measured using baseline and quarterly surveys assessing CaP awareness, knowledge, attitude, health beliefs, perceived control, intentions, and cues to action. Descriptive statistics were used to compare participants' information at baseline and at 3-month follow-up. Results: A total of 173 participants were included in this analysis; 57.9% were ≥ 60 years, and 92.2% were US-born Black men. Prostate cancer knowledge increased from baseline to 3-month follow-up. The median score rose from 4±1.29 at baseline, with the mean increasing to 4.24±1.10. Attitudes towards Cap screening declined marginally from 12.58±2.15 to 12.27±2.40. Health beliefs showed a clear upward shift, with the mean increasing from 22.86±3.0 at baseline to 23.20±2.82 after 3 months of intervention. Additionally, cues to action also improved, with the mean increasing from 2.78±1.67 to 3.25±1.45. Only the cues-to-action index showed a statistically significant difference (p = 0.018), with higher scores observed after 3 months of intervention. Conclusion: Across the four core constructs—prostate cancer knowledge, testing attitudes, health beliefs, and cues to action—outcomes at follow-up demonstrated modest but consistent improvements compared to those of baseline, alongside slightly reduced variability for most domains. Overall, the evaluation showed that CoLLab REACH services improved knowledge, enhanced stronger health beliefs, and significantly increased cues to action, while testing attitudes remained comparatively stable. Citation Format: Folakemi T. Odedina, Opeyemi Oreoluwa Bolajoko, Quincy A. Wimberly, Daniel W. Lee, Floyd B. Willis, Toshiko Moultrie, Wayne Ford, Derry Green, Arnold J. Merriweather, Michelle Fudge. The impact of the Community Living Lab learning health system on the prostate cancer knowledge, attitudes, beliefs, and cues to action of Black men [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(8_Suppl):Abstract nr LB324.